Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris

被引：2

作者：

Andrew, Kashini

Dhariwal, Sukhjit K.

Szczecinska, Weronika

机构：

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2023年 / 48卷 / 09期

关键词：

D O I：

10.1093/ced/llad173

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1055 / 1056

页数：2

共 5 条

[1] IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy? [J].

Atal, Shubham ;

Fatima, Zeenat .

PHARMACEUTICAL MEDICINE, 2020, 34 (04) :223-231

[2] Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials [J].

Belletti, Alessandro ;

Campochiaro, Corrado ;

Marmiere, Marilena ;

Likhvantsev, Valery ;

Yavorovskiy, Andrey ;

Dagna, Lorenzo ;

Landoni, Giovanni ;

Zangrillo, Alberto ;

Hajjar, Ludhmila Abrahao .

ANNALS OF INTENSIVE CARE, 2021, 11 (01)

[3]

Masjedi M, 2017, IRAN J PHARM RES, V16, P1223

[4]

Sanders WJ, 2017, Biomedical Dermatology, V1, DOI [10.1186/s41702-017-0008-1, 10.1186/s41702-017-0008-1, DOI 10.1186/S41702-017-0008-1]

[5] Pathogenic and protective roles of cytokines in pemphigus: A systematic review [J].

Tavakolpour, Soheil ;

Mahmoudi, HamidReza ;

Mirzazadeh, Azin ;

Balighi, Kamran ;

Darabi-Monadi, Sahar ;

Hatami, SeyedehBehnaz ;

GhasemiAdl, Mojtaba ;

Daneshpazhooh, Maryam .

CYTOKINE, 2020, 129

← 1 →